Share on LinkedInShare on LinkedIn

PODCAST · 05 DECEMBER 2025

Is Psychedelic-assisted Therapy The Next Step In Workplace Wellness? (Podcast)

What if employers could improve mental health, lower costs, and boost retention by offering treatments once considered unconventional?

United StatesEmployment and HR

What if employers could improve mental health, lower costs, and boost retention by offering treatments once considered unconventional?

Brett Gelbord sits down with Jillie Gordon Foerster of Dykema's Employee Benefits Group and Sherry Rais, Co-Founder & CEO of Enthea, to explain how ketamine-assisted therapy, psilocybin therapy, and non-psychedelic options like the stellate ganglion block are becoming part of workplace wellness strategies. Listen as they examine how these treatments support employees who need help the most, why the data behind them is gaining attention, and what it takes to seamlessly integrate these services with their carrier.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from